This article is for informational and educational purposes only and does not constitute medical advice. Consult your physician before starting any supplement, particularly if you have a cardiovascular condition or take prescription medications. UTCardiothoracicSurgery.com Editorial Team | January 2026. This article may contain affiliate links. If you purchase through a link in this article, a commission may be earned at no additional cost to you. This does not affect the objectivity of the information presented. FTC disclosure required by 16 C.F.R. Part 255.
Cardiac Safety Summary: Red Boost
- Product Type: Herbal supplement (male vitality formula)
- Key Ingredients: L-citrulline, nettle root, horny goat weed (epimedium), tongkat ali, ferula asafoetida
- Price Range: Approximately $59–$199 per bottle (depending on package/subscription)
- Refund Policy: 180-day money-back guarantee (not independently verified)
- Cardiac Drug Interactions: Potential interactions with blood pressure medications, beta-blockers, nitrate vasodilators, and antiplatelet/anticoagulant agents due to L-citrulline and herbal vasodilatory compounds
- Quick Answer: Red Boost combines L-citrulline with several botanical extracts marketed to support male blood flow and stamina. For cardiac patients—particularly those on antihypertensives, nitrates, or anticoagulants—the additive vasodilatory effects warrant medical review before use. Clinical evidence supporting the full formula is limited.
What Makes This Review Different
Many Red Boost discussions focus on efficacy claims or general satisfaction. This review prioritizes the cardiac safety lens that distinguishes UTCardiothoracicSurgery.com: for patients managing blood pressure, heart disease, or taking medications that affect vascular tone, vasodilatory supplements pose specific interaction risks that go unaddressed in mainstream wellness reviews. Cardiac patients deserve to know whether a vasodilatory supplement can lower blood pressure further, interfere with nitrate therapy, or potentiate anticoagulant effects. This assessment directly answers questions a cardiologist would ask before approving use.
What Red Boost Is: Verified Product Summary
Red Boost is marketed as a dietary supplement designed to support male sexual vitality and blood flow. According to available product information, the formula is distributed as a powder intended to be mixed with water or beverages and consumed daily. The product is presented as a proprietary blend rather than fully transparent label dosing for all ingredients. The manufacturer positions Red Boost as supporting “nitric oxide production” and “blood vessel function”—claims rooted in vascular physiology but not independently verified on the label itself. The product format is convenient for those avoiding capsules, though proprietary blending creates challenges for dose verification and cardiac risk assessment.
The Label vs. Marketing Analysis: Red Boost Claims Under Scrutiny
Red Boost marketing emphasizes “clinical-grade” ingredients and “proven” vasodilatory effects, yet the actual ingredient panel structure reveals significant transparency gaps. The formula relies on a proprietary blend, which means individual ingredient doses are not disclosed to consumers or healthcare providers—a critical omission for cardiac patients evaluating drug interactions. Marketing materials reference L-citrulline as the “hero ingredient” supporting nitric oxide production, but the label does not specify the gram amount per serving, making it impossible to compare against clinical study doses (typically 5–10 grams in research settings). Additionally, the marketing suggests the formula is “formulated by experts” and “studied,” but no published clinical trials of the complete Red Boost formula appear in PubMed or major clinical databases. The herbs included—nettle, epimedium, tongkat ali, asafoetida—are presented as “ancient remedies,” a marketing frame that differs sharply from mechanism-of-action evidence. For cardiac patients, this gap between marketing hype and disclosed dosing is not merely a consumer protection issue; it is a safety concern, because undisclosed doses of vasodilatory compounds cannot be properly evaluated by cardiologists managing blood pressure or using medications that depend on vascular tone balance.
Red Boost Ingredient Evidence and Dose Analysis
L-Citrulline: The most clinically studied component. Research shows 5–10 grams daily supports nitric oxide synthesis and endothelial function. A 2011 randomized controlled trial in the Journal of Sexual Medicine found citrulline at 1.5 grams three times daily improved erectile function in men with mild-to-moderate dysfunction. However, Red Boost does not disclose its citrulline dose; if the product delivers sub-therapeutic amounts (<3 grams total), the vasodilatory signal may be minimal. Conversely, if it delivers 8+ grams, the blood pressure-lowering effect becomes clinically relevant for cardiac patients.
Nettle Root (Urtica dioica): Traditionally used for urinary symptoms; minimal evidence for vascular effects. No published RCTs support a vasodilatory mechanism at typical supplement doses. Its inclusion is primarily traditional, not evidence-based.
Horny Goat Weed (Epimedium): Contains icariin, a PDE5 inhibitor analog. In vitro studies suggest vasodilatory potential, but clinical evidence is preliminary, with only small, poorly controlled trials available. The dose in Red Boost is undisclosed, limiting assessment of whether it reaches pharmacologically relevant levels.
Tongkat Ali (Eurycoma longifolia): Used in traditional medicine; some evidence for male sexual function. A 2012 meta-analysis noted improvements in erectile function in several small studies, but mechanism and safety in cardiac populations are not well-characterized. No cardiac drug interaction data are available.
Ferula Asafoetida: A resin extract traditionally used in Ayurvedic medicine. Limited published evidence for any vascular or sexual function benefit. Inclusion appears marketing-driven rather than evidence-driven.
Overall, only L-citrulline and possibly icariin (from epimedium) have meaningful clinical evidence, and both are presented in undisclosed doses. The other ingredients add proprietary opacity without established clinical contribution.
Red Boost Cardiac Safety Profile: Drug Interactions and Medication Concerns
This is the critical section for cardiac patients. Red Boost's vasodilatory ingredients present specific interaction risks:
Interaction with Nitrate Vasodilators: Patients taking nitroglycerin (sublingual or long-acting), isosorbide dinitrate, or isosorbide mononitrate should be particularly cautious. L-citrulline works synergistically with nitrates to lower blood pressure and may cause dangerous hypotension. This is not theoretical: combining nitrates with PDE5 inhibitors (which icariin mimics) has caused severe, sometimes fatal hypotensive episodes. Even though Red Boost is not a prescription PDE5 drug, the additive vasodilatory effect warrants physician review before use.
Interaction with Antihypertensive Medications: Patients on ACE inhibitors (lisinopril, enalapril), angiotensin II receptor blockers (losartan, valsartan), beta-blockers (metoprolol, atenolol), calcium channel blockers (amlodipine, diltiazem), or diuretics face additional blood pressure lowering. For those already on tight blood pressure control or with borderline hypotension, Red Boost could tip blood pressure into symptomatic ranges, risking syncope, stroke, or myocardial ischemia.
Interaction with Antiplatelet and Anticoagulant Medications: Some botanical ingredients (particularly asafoetida and nettle) have weak anticoagulant or antiplatelet properties reported in preliminary research. Patients on aspirin, clopidogrel (Plavix), warfarin, apixaban (Eliquis), or other anticoagulants may face compounded bleeding risk, though the clinical significance at typical supplement doses remains uncertain. Nevertheless, the mechanism is plausible and warrants precaution.
What the Manufacturer Discloses: Red Boost marketing does not explicitly warn against use with nitrates, blood pressure medications, or anticoagulants. This omission is a red flag, particularly given the vasodilatory mechanism. A responsible supplement company would include cardiac drug interaction warnings on the label; the absence of such warnings suggests either insufficient risk assessment or deliberate omission to avoid deterring customers.
Bottom Line: Cardiac patients should not use Red Boost without explicit cardiologist approval, particularly if taking any vasodilatory, antihypertensive, or anticoagulant medication. The undisclosed ingredient doses make medical evaluation difficult and shift risk to the patient.
What to Realistically Expect and Common Questions Before Buying
Expectations for any supplement in this category should rest on its label and the published research rather than on general impressions. Red Boost's stated benefits (stamina, blood flow, and sexual function) are the same outcomes studied in the clinical literature on L-citrulline and erectile function, but the product's undisclosed doses mean a reader cannot tell whether the formula reaches the amounts used in those trials. Results in any study depend heavily on dose, duration of use, and baseline health, and the same factors are likely to shape individual outcomes. Erectile difficulty can also be an early sign of cardiovascular disease, so persistent symptoms are worth a medical evaluation rather than a trial of an over-the-counter product. Readers who want to judge the product should check the label for ingredient amounts per serving, compare those amounts with the doses studied in research, and review the refund terms directly with the manufacturer. Anyone with heart disease, blood pressure concerns, or a prescription for nitrates or anticoagulants should ask a clinician before starting, and should bring the full ingredient list to that appointment.
Red Boost Pricing and Refund Terms
Red Boost is offered in tiered packages: single-bottle purchases at approximately $59, multi-bottle bundles at lower per-unit costs (reportedly down to $39 per bottle in 3- or 6-bottle packages), and subscription options offering ongoing deliveries at discounted rates. The manufacturer advertises a 180-day money-back guarantee, though the specifics—refund start date, return shipping costs, and whether opened or partial bottles are refundable—are not independently verified. Customers are advised to review the full refund policy directly on the Red Boost official website or contact customer support before purchase. Pricing is subject to change. Verify current pricing and refund terms on the manufacturer's official listing.
Red Boost Buyer Takeaway: What the Evidence Supports and What Remains Uncertain
Red Boost contains L-citrulline, which has legitimate, published evidence supporting its role in nitric oxide production and vascular function at clinical doses of 5–10 grams daily. For non-cardiac men interested in natural support for sexual function, the presence of this ingredient is a rational starting point. However, the formula's proprietary blending obscures actual serving sizes, preventing meaningful dose assessment. For cardiac patients, Red Boost presents a higher-risk profile: the vasodilatory mechanism, while potentially beneficial in isolation, poses interaction risks with nitrates, blood pressure medications, and anticoagulants that the manufacturer does not adequately disclose. The remaining botanical ingredients (nettle, epimedium, tongkat ali, asafoetida) have limited clinical evidence and unknown interaction profiles. A cardiac patient considering Red Boost should obtain written approval from their cardiologist and should not use the product if taking nitrate therapy. Those on blood pressure or anticoagulant medications should present the ingredient list to their physician before starting. Because the complete formula has not been studied in published clinical trials and its dosing is proprietary, efficacy and safety remain largely unproven in controlled settings.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for educational purposes only and does not constitute medical advice. Results vary by individual. Consult your physician before starting any supplement, particularly if you take cardiovascular or metabolic medications.
Related Reading on UT Cardiothoracic Surgery
- PDE5 Inhibitors and Blood Pressure Medications: Drug Interactions Every Man on Cardiac Meds Should Understand
- Erectile Dysfunction and Heart Disease: Why ED May Be an Early Warning Sign of Cardiovascular Problems
- Compounded ED Combinations and Heart Medications: Nitrates, Blood Pressure, and Cardiac Safety
- Cardiovascular Safety Considerations: Max Force Power Male Enhancement vs. Prescription ED Medications